Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 02/20/2026 | CALL | $47.00 | 7,476 | +7,002 | +1,477.22% |
| 02/20/2026 | PUT | $47.01 | 7,000 | +7,000 | |
| 02/20/2026 | PUT | $45.00 | 4,634 | +2,614 | +129.41% |
| 09/18/2026 | CALL | $46.00 | 1,652 | +1,624 | +5,800.00% |
| 03/20/2026 | PUT | $30.00 | 9,014 | +999 | +12.46% |
| 01/30/2026 | PUT | $47.00 | 1,778 | +592 | +49.92% |
| 02/06/2026 | CALL | $46.00 | 6,977 | -234 | -3.25% |
| 01/30/2026 | PUT | $55.00 | 1,513 | -333 | -18.04% |
| 01/30/2026 | CALL | $55.00 | 2,175 | -393 | -15.30% |
| 01/30/2026 | CALL | $46.00 | 1,827 | -854 | -31.85% |
| 03/20/2026 | CALL | $47.00 | 14,026 | -6,940 | -33.10% |
| 03/20/2026 | PUT | $47.01 | 13,340 | -7,000 | -34.41% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.57% | 9.93M | 1.25B |
| Vanguard International Growth Fund | 2.53% | 9.77M | 1.23B |
| Vanguard 500 Index Fund | 1.98% | 7.64M | 961.76M |
| Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 1.31% | 5.08M | 639.64M |
| Fidelity 500 Index Fund | 0.94% | 3.62M | 456.08M |
| SPDR S&P 500 ETF Trust | 0.92% | 3.57M | 449.61M |
| Vanguard Specialized-Health Care Fund | 0.90% | 3.49M | 439.87M |
| Growth Fund Of America Inc | 0.80% | 3.11M | 391.58M |
| iShares Core S&P 500 ETF | 0.76% | 2.95M | 371.32M |
| Vanguard U.S. Growth Fund | 0.75% | 2.88M | 362.55M |
Stock Market Today, Jan. 20: ImmunityBio Soars Again After FDA Outlines Resubmission Path for ANKTIVA in Bladder Cancer
01/26 06:02 pm
The Motley Fool
Read moreHecla Mining, Moderna, And Micron Are Among the Top 10 Large-Cap Gainers Last Week (Jan. 19-Jan. 23): Are the Others in Your Portfolio?
01/25 10:01 am
Benzinga
Read moreLipid Nanoparticle Manufacturing Market: An 18.9% CAGR Market Driven by Nucleic Acid Therapies
01/23 11:00 am
GlobeNewswire Inc.
Read moreStock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Rise As BEA Pegs Q3 GDP At 4.4%— Microsoft, Moderna, Intel In Focus (UPDATED)
01/22 09:46 am
Benzinga
Read moreModerna Stock Rallies as Oncology Results Improve the Platform’s Value Case
01/21 03:38 pm
Investing.com
Read moreStocks Rebound On Trump's Remarks, Natural Gas Rockets: What's Moving Markets Wednesday?
01/21 02:57 pm
Benzinga
Read moreModerna Pops 17%—Is There Life in MRNA, Down 90% from COVID High?
01/21 12:14 pm
Investing.com
Read moreModerna–Merck Cancer Vaccine Shows Durable Benefit At 5 Years In High-Risk Melanoma
01/20 05:21 pm
Benzinga
Read moreSilver Jumps To $89 After Soft CPI, JPMorgan Falls 3%: What's Moving Markets Tuesday?
01/13 02:04 pm
Benzinga
Read moreMy Top 5 Stocks to Buy in Early 2026
01/07 05:15 am
The Motley Fool
Read moreSilver Jumps 6%, Platinum Up 8%, Palladium Up 11% As Metal Shock Erupts: What's Moving Markets Friday?
12/26 01:47 pm
Benzinga
Read moreNanobiotechnology Market to Hit USD 420.2 Billion by 2034, Fueled by 2025 Traffic Growth and Strategic Material & Product Innovations
12/17 11:00 am
GlobeNewswire Inc.
Read moreXOMA Royalty Enters into Agreement to Acquire Generation Bio
12/15 06:00 pm
GlobeNewswire Inc.
Read moreImmatics Presents IMA203CD8 PRAME Cell Therapy Data from Ongoing Dose Escalation and Shows Promising Initial Anti-tumor Activity in PRAME-Positive Tumors at ESMO-IO 2025 Congress
12/11 08:00 am
GlobeNewswire Inc.
Read moreSeasonal Vaccines Market Accelerating Growth and Rising Opportunities Through 2035
12/03 11:00 am
GlobeNewswire Inc.
Read moreWhere Will Vertex Pharmaceuticals Be in 5 Years
11/27 07:31 am
The Motley Fool
Read moreAI Just Sparked Biotech's Biggest Rally Since 2004 — Why Isn't Anyone Talking About It?
11/25 04:14 pm
Benzinga
Read moreCytomX Therapeutics to Present at the Jefferies London Healthcare Conference
11/13 09:00 am
GlobeNewswire Inc.
Read moreImmatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER®) Pipeline with Data on IMA402 (PRAME) and IMA401 (MAGEA4/8) and Announces Next Development Steps
11/12 08:00 am
GlobeNewswire Inc.
Read moreCytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025
10/30 08:00 am
GlobeNewswire Inc.
Read moreModerna Stops CMV Program As Vaccine Falls Short In Preventing Infection
10/23 10:26 am
Benzinga
Read morePrediction: Moderna Will Soar Over the Next 5 Years. Here's 1 Reason Why.
10/22 01:10 pm
The Motley Fool
Read moreThese 3 Beaten-Down Healthcare Stocks Could Have Farther to Fall
10/21 05:05 am
The Motley Fool
Read moreStock Market Today: S&P 500, Nasdaq, Dow Jones Futures Rise— Micron, Bitmine, Coinbase In Focus
10/20 05:15 am
Benzinga
Read moreWhy Moderna Might Be a One-Hit Wonder
10/15 04:08 pm
The Motley Fool
Read more6 Healthcare Stocks Positioned to Soar After Trump-Pfizer Deal
10/02 12:15 pm
Investing.com
Read moreThese 50%+ 'AI Dividends' Could Ruin Your Retirement
10/02 05:21 am
Investing.com
Read moreLyme Disease Market Growth Highlighted by Pipeline Advances and Expanding Patient Population | DelveInsight
10/01 01:00 pm
GlobeNewswire Inc.
Read more2 Beaten-Down Stocks to Buy and Hold for a Decade
09/30 07:30 am
The Motley Fool
Read moreRobert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough'
09/26 12:08 am
Benzinga
Read moreModerna's COVID-19 Vaccine Update Boosts Antibodies 16-Fold, Data Shows
09/23 12:06 pm
Benzinga
Read moreModerna Reports 8-Fold Jump In Antibodies With Updated Spikevax
09/16 10:49 am
Benzinga
Read moreFDA Moves To Publicize Data On Pregnant Women's Covid Vaccine Side Effects
09/10 01:21 pm
Benzinga
Read moreGlobal Industrial Biomanufacturing Market Report 2026-2036: Sustainability, Synthetic Biology, and Circular Economy Drive Growth
09/10 04:39 am
GlobeNewswire Inc.
Read moreUntreated Metastatic or Unresectable Melanoma Clinical Trial Pipeline Expands as 10+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight
08/26 01:00 pm
GlobeNewswire Inc.
Read moreUnderstanding the Nanomedicine Landscape: Key Players and Emerging Trends
08/21 04:38 am
GlobeNewswire Inc.
Read moreIf You're in Your 30s, Consider Buying These 2 Healthcare Stocks
08/17 09:30 am
The Motley Fool
Read moreCDC Shooting Linked To Suspect's COVID-19 Vaccine Beliefs, Former Staff Blame RFK Jr. Hostility Toward Agency
08/12 01:41 pm
Benzinga
Read moreGlobal Cancer Vaccines Market to Surpass USD 15.00 Billion by 2032, Unlocking Over USD 10 Billion in New Growth Opportunities | MarketsandMarkets™.
08/11 09:00 am
GlobeNewswire Inc.
Read moreCytomX (CTMX) Q2 Revenue Drops 26%
08/07 06:29 pm
The Motley Fool
Read moreLipid Nanoparticles Market Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2034
08/05 06:00 am
GlobeNewswire Inc.
Read moreModerna's Key Patent Win Overshadowed By Gloomy Outlook
08/01 08:44 am
Benzinga
Read moreAlnylam Pharmaceuticals Q2 Earnings Crush Estimates, Stock Hits 52-Week High On Upbeat Forecast
07/31 03:36 pm
Benzinga
Read moreOpinion: It's Time to Load Up on This Biotech Giant After Its 80% Crash
07/14 08:30 pm
The Motley Fool
Read moreDelta Air, Moderna And Coinbase Are Among Top Large Cap Gainers Last Week (July 7-July 11): Are The Others In Your Portfolio?
07/13 11:02 am
Benzinga
Read moreWhere Will Moderna Be in 10 Years?
07/05 05:10 am
The Motley Fool
Read moreModerna's mRNA Flu Vaccine Outperforms Standard Shots
06/30 09:51 am
Benzinga
Read moreFlu RNA Vaccines Market Research Report 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and Challenges
06/20 10:59 am
GlobeNewswire Inc.
Read moreModerna Beats Alnylam Appeal In COVID Vaccine Patent Case
06/05 11:59 am
Benzinga
Read more